• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

VBI Vaccines

European Medicines Agency
Pharma

EMA expands nods for BMS, Eli Lilly, Novartis drugs

In an important update for Eli Lilly, EMA's CHMP recommended the use of Verzenios as an adjuvant treatment for HR+/HER2- breast cancer.
Angus Liu Feb 25, 2022 11:42am
hepatitis B virus

FDA approves VBI's PreHevbrio just as HBV market is set to grow

Dec 1, 2021 10:34am
newspaper

Heplisav-B; Janssen and more—News of Note

Feb 27, 2019 9:14am
newspaper

Zika, VBI Vaccines and more—News of Note

Aug 21, 2018 3:25pm
CMV virus

VBI Vaccines touts positive phase 1 data for CMV vaccine

May 15, 2018 8:43am
vaccine

Vical’s Astellas-partnered CMV vaccine falls short in phase 3

Jan 22, 2018 3:32pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy